Intech Biopharm Corporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was TWD 4.491 million compared to TWD 4.030 million a year ago. Operating loss was TWD 77.250 million compared to TWD 57.434 million a year ago. Net loss was TWD 80.941 million compared to TWD 55.853 million a year ago. Basic loss per share was TWD 1.01 compared to TWD 0.7 a year ago. For the nine months, total revenue was TWD 12.807 million compared to TWD 12.227 million a year ago. Operating loss was TWD 219.602 million compared to TWD 175.790 million a year ago. Net loss was TWD 226.790 million compared to TWD 168.515 million a year ago. Basic loss per share was TWD 2.83 compared to TWD 2.19 a year ago.